| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2154827 | Nuclear Medicine and Biology | 2007 | 11 Pages |
Abstract
Since receptor-bound radioligand is not internalized by endothelial cells, disintegrins may provide an advantage for targeting αvβ3 on vasculature because they bind strongly to surface receptors and are not readily displaced.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Linda C. Knight, Jan E. Romano, Stephen C. Cosenza, Nabisa M. Iqbal, Cezary Marcinkiewicz,